Pulmonary CCR Conference

The Pulmonary Center does research to improve medicine, which is facilitated by ensuring that scientists and clinicians are in regular and open contact. The Pulmonary Combined Clinical and Research (CCR) Conference is a manifestation of that. The CCR Conference unifies two efforts which were previously distinct. In Pulmonary Grand Rounds, physicians present cases and discuss cutting-edge clinical approaches to medical challenges. In Work-in-Progress Seminars, scientists present research questions, experiments, results, and interpretations, discussing implications for advancing biology and medicine. The Pulmonary CCR Conference includes both of these activities in one extended session. As often as possible, the 2 components are coordinated so that the medical cases and the research questions are directly and immediately mutually informative. All Pulmonary Center members (faculty, trainees, and staff, from all disciplines) participate in both components. Pulmonary medicine and research benefit when scientists, clinicians, and clinician-scientists all learn from and inform each other meaningfully and productively.


The Pulmonary CCR conference occurs weekly on Wednesdays from 3:30pm-5:30pm.

Pulmonary CCR Conference Fall/Winter 2019 Schedule:

Date Clinical Cases Scientific Seminar
9/4 Justin Lui,
Lakshmana Swamy
Katrina Traber
“Neutrophil Remodeling During Pneumonia”
9/11 Samuel Belok
Wei He
Renda Wiener
9/18 Nicholas Bosch
Stephanie Hon
Jay Mizgerd
“Pneumonia and the lung-resident immune system”
9/25 Nicholas Bosch
Andrew Berical
Darrell Kotton
“Stem cell/disease modeling”
10/2 Jessica Gereige
Kari Gillmeyer
Paul Maglione
10/9 Raj Parikh
Kate Steinberg
George O’Connor
“COPD/GWAS Lung function”
10/16 TBD TBD
10/23 TBD TBD
10/30 TBD TBD
11/6 TBD TBD
11/13 TBD TBD
11/20 TBD TBD
11/27 Thanksgiving
12/4 TBD TBD
12/18 TBD TBD
12/25 Intercession
1/1 Intercession

Work in Progress Spring/Summer 2019 Schedule:

Date Speaker Presentation Title
1/4 Michael Herriges/Yuri Kim “Transplantation of primary and PSC-derived lung epithelial progenitor cells”
1/11 Renda Wiener “Untangling overuse: PDE-5-inhibitors for Groups 2/3 Pulmonary Hypertension”
1/18 Sarah Mazzilli

“Molecular Characterization of a Pre-Clinical Model for Lung Cancer Interception”

1/25 Kim Barker/Andrew Berical Pneumococcal exposures elicit resident memory B cells poised to secrete class-switched antibodies in the lung”

“Induced Pluripotent Stem Cells and Personalized Cystic Fibrosis Drug Prediction”

2/1 Hannah Wunsch, University of Toronto “ICU staffing models: do they make a difference?”
2/8 Judy Campisi- Jerome Brody Lecture “Cellular Senescence, the Lung and Aging: The Jerry Brody Connection”
2/15 Kristine Abo/Sean Corbett “Pluripotent Stem Cell-Based Modeling of Cigarette Smoke Injury”

“Identifying Lung-Cell-Type-Associated Responses to Compound Perturbation”

2/22 Emad Arafa/Nathan Kingston “Alveolar Macrophages Dynamics During Pneumococcal Pneumonia”

“Roles for Hippo Pathway Effectors Taz and Yap in Fibroblast Populations During Pulmonary Fibrosis”

3/1 Anukul Shenoy/ Filiz Korkmaz “Lung-Resident CD4+ Memory T Cell and Epithelial Crosstalk During Heterotypic Immunity”
3/8 Roberto Machado, Indiana University School of Medicine “NAMPT and pulmonary vascular remodeling in PAH”
3/15 Jussi Saukkonen “Phenobarbital in the treatment of acute alcohol withdrawal syndrome”
3/22 Claire Burgess/Julia Hicks-Berthet “Generation of human alveolar epithelial type 1 cells from pluripotent stem cells”

“Yap and Taz-regulated control of goblet cell fate in the airway epithelium”

3/29 Barbara Ludeke/Michael Breen “Towards a linked RNA synthesis and RNA capping assay for RSV”

“Characterizing the lung B memory cell population after respiratory viral infection”

4/5 Bela Suki “Bioengineering approaches toward understanding honeycombing in pulmonary fibrosis and tissue deterioration in emphysema”
4/12 Kari Gillmeyer/Yuliang (Leon) Sun “Delivery of care for patients with pulmonary hypertension”

“Establishing an iPSC-derived AEC2s model to study childhood interstitial lung disease”

4/19 Alicia Wooten/Stephanie Hon “Phosphodiesterase 2 deletion in Streptococcus pneumoniae D39 elicits a robust type I interferon response in macrophages”

“Single Cell Sequencing and Lineage Tracing of the Origins of Pulmonary Vasculature”

4/26 Nick Bosch/Rhiannon Werder “Derivation and Validation of a Novel Measure of Septic Shock Severity”

“Understanding the Function of COPD Susceptibility Genes using CRISPRi-Targeted Human Induced Pluripotent Stem Cell (iPSC)-Derived Lung Epithelium”

5/3 James Murphy, M.D. “Critical Care Quality Improvement at BMC”
5/10 Eric Abston/ Ming-Ming Lee “Noninvasive Quantification of Fibrotic Lung Disease: of Mice and Men”

“Predicting future pneumonia from baseline clinical risk factors and blood protein markers”

5/17 No Seminar- ATS TBD
5/24 No Seminar- ATS TBD
5/31 Avi Spira- Mary Williams Lecture “The Road Rarely Traveled: a 20-year Journey Towards Early Lung Cancer Detection.”
6/7 Timothy Blackwell, Vanderbilt University Medical Center – Gordon Snider Memorial Lecture “Progress in Understanding Genetic Mechanisms of Pulmonary Fibrosis.”
6/14 Tien Peng- UCSF “Traversing the Wall: Signaling Across the Basement Membrane in Lung Regeneration.”
6/21 Elim Na/Carolina Lyon De Ana “Determining epithelial-specific roles for the lung-protective cytokine LIF during pneumonia.”

“The T-lymphocytic landscape of heterotypic immune lungs.”

6/28 Kostas Alysandratos “Pluripotent stem cells to unravel the role of alveolar type 2 epithelial cells in the pathogenesis of pulmonary fibrosis.”
7/5 No Seminar
7/12 Christine Odom/Adeline Matsculat “Liver-dependent lung defense during sepsis.”

“Defining molecular signals that influence airway basal cell renewal and growth.”

7/19 Barbara Ludeke “Towards a High Throughput Screening Assay for Multiple Activities of RSV RNA Polymerase.”
7/26 Alan Fine “Lung Lymphatic Remodeling”